Skip to main content

Gastric Cancer: Synopsis and Epidemiology of Gastric Cancer

  • Chapter
  • First Online:
Helicobacter pylori

Abstract

Gastric cancer is the fifth most common cancer accounting for close to 7 % of all human cancers. Despite the decrease in incidence, gastric cancer remains the most common cause of gastrointestinal cancer-related death, with more than 800,000 fatalities annually. The disease is more common in men than in women, and non-cardia gastric cancer is twice as common as cardia cancer. More than two-thirds of gastric cancer occur in East Asia, in particular, in China, Japan, and Korea. There are large regional and racial differences in the incidence of gastric cancer. These differences are related to prevalence of Helicobacter pylori (H. pylori), diet, and other risk factors. The mortality of gastric cancer closely matches the regional differences in incidence. The age-standardized incidence and mortality rates of gastric cancer are expected to further decrease due to improvement in socioeconomic conditions and decreasing prevalence of H. pylori. Population screening and intervention, as well as general health measures such as antismoking campaigns, can accelerate the changing epidemiology of gastric cancer. In the absence of such measures, gastric cancer will for long remain a very common and lethal disease. This chapter reviews the epidemiology of gastric cancer, with focus on regional differences in incidence and mortality, risk factors for gastric cancer. It further summarizes the changing epidemiology of gastric cancer in recent decades and the expected future trends.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Boas I. Diagnostik und Therapie der Magenkrankheiten. Leipzig: Georg Thieme; 1925.

    Google Scholar 

  2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58:71–96.

    Article  PubMed  Google Scholar 

  3. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385:117–71.

    Article  Google Scholar 

  4. Fock KM. Review article: the epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther. 2014;40:250–60.

    Article  CAS  PubMed  Google Scholar 

  5. Tanaka M, Ma E, Tanaka H, Ioka A, Nakahara T, Takahashi H. Trends of stomach cancer mortality in Eastern Asia in 1950-2004: comparative study of Japan, Hong Kong and Singapore using age, period and cohort analysis. Int J Cancer. 2012;130:930–6.

    Article  CAS  PubMed  Google Scholar 

  6. Forman D, Bray F, Brewster DH, Gombe Mbalawa C. Kohler B, Piñeros M, et al. Cancer incidence in five continents, vol. X (electronic version). Lyon: International Agency for Research on Cancer; 2013. http://ci5.iarc.fr/Default.aspx. Accessed 11 Jan 2015.

  7. Colquhoun A, Arnold M, Ferlay J, Goodman KJ, Forman D, Soerjomataram I. Global patterns of cardia and non-cardia gastric cancer incidence in 2012. Gut. 2015;64:1881–8.

    Article  CAS  PubMed  Google Scholar 

  8. Arnold M, Moore SP, Hassler S, Ellison-Loschmann L, Forman D, Bray F. The burden of stomach cancer in indigenous populations: a systematic review and global assessment. Gut. 2014;63:64–71.

    Article  PubMed  Google Scholar 

  9. Camargo MC, Anderson WF, King JB, Correa P, Thomas CC, Rosenberg PS, et al. Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut. 2011;60:1644–9.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Lim KG. Malays in peninsular Malaysia may have the lowest incidence of stomach cancer in the world. Med J Malaysia. 2009;64:91–2.

    CAS  PubMed  Google Scholar 

  11. Kimman M, Norman R, Jan S, Kingston D, Woodward M. The burden of cancer in member countries of the Association of Southeast Asian Nations (ASEAN). Asian Pac J Cancer Prev. 2012;13:411–20.

    Article  PubMed  Google Scholar 

  12. Isobe Y, Nashimoto A, Akazawa K, Oda I, Hayashi K, Miyashiro I, et al. Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry. Gastric Cancer. 2011;14:301–16.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Shen ZL, Song KY, Ye YJ, Xie QW, Liang B, Jiang K, et al. Significant differences in the clinicopathological characteristics and survival of gastric cancer patients from two cancer centers in China and Korea. J Gastric Cancer. 2015;15:19–28.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Dassen AE, Dikken JL, Bosscha K, Wouters MW, Cats A, van de Velde CJ, et al. Gastric cancer: decreasing incidence but stable survival in the Netherlands. Acta Oncol. 2014;53:138–42.

    Article  PubMed  Google Scholar 

  15. Seyedin S, Wang PC, Zhang Q, Lee P. Benefit of adjuvant chemoradiotherapy for gastric adenocarcinoma: a SEER population analysis. Gastrointest Cancer Res. 2014;7:82–90.

    PubMed  PubMed Central  Google Scholar 

  16. Wang J, Sun Y, Bertagnolli MM. Comparison of gastric cancer survival between Caucasian and Asian patients treated in the United States: results from the Surveillance Epidemiology and End Results (SEER) database. Ann Surg Oncol. 2015;22:2965–71.

    Article  PubMed  Google Scholar 

  17. Warthin A. Heredity with reference to carcinoma: as shown by the study of the cases examined in the pathological laboratory of the University of Michigan. Arch Intern Med. 1913;12:546–55.

    Article  Google Scholar 

  18. Capelle LG, Van Grieken NC, Lingsma HF, Steyerberg EW, Klokman WJ, Bruno MJ, et al. Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands. Gastroenterology. 2010;138:487–92.

    Article  PubMed  Google Scholar 

  19. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the evaluation of carcinogenic risks to humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1–241.

    Google Scholar 

  20. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001;49:347–53.

    Article  Google Scholar 

  21. Simán JH, Engstrand L, Berglund G, Forsgren A, Florén CH. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma. Scand J Gastroenterol. 2007;42:933–40.

    Article  PubMed  Google Scholar 

  22. Plummer M, Franceschi S, Vignat J, Forman D, de Martel C. Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015;136:487–90.

    Article  CAS  PubMed  Google Scholar 

  23. Kuipers EJ, Pérez-Pérez GI, Meuwissen SG, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst. 1995;87:1777–80.

    Article  CAS  PubMed  Google Scholar 

  24. Basso D, Zambon CF, Letley DP, Stranges A, Marchet A, Rhead JL, et al. Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology. 2008;135:91–9.

    Article  CAS  PubMed  Google Scholar 

  25. Persson C, Canedo P, Machado JC, El-Omar EM, Forman D. Polymorphisms in inflammatory response genes and their association with gastric cancer: a HuGE systematic review and meta-analyses. Am J Epidemiol. 2011;173:259–70.

    Article  PubMed  Google Scholar 

  26. Hunt RH, Camilleri M, Crowe SE, El-Omar EM, Fox JG, Kuipers EJ, et al. The stomach in health and disease. Gut. 2015;64:1650–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Lee YC, Chen TH, Chiu HM, Shun CT, Chiang H, Liu TY, et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut. 2013;62:676–82.

    Article  PubMed  Google Scholar 

  28. Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, et al. Kyoto global consensus report on management of Helicobacter pylori gastritis. Gut. 2015;64:1353–67.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection – the Maastricht IV/Florence Consensus Report. Gut. 2012;61:646–64.

    Article  CAS  PubMed  Google Scholar 

  30. Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O’Connor A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa. Endoscopy. 2012;44:74–94.

    Article  CAS  PubMed  Google Scholar 

  31. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004;291:187–94.

    Article  CAS  PubMed  Google Scholar 

  32. de Vries AC, Kuipers EJ, Rauws EA. Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn? Am J Gastroenterol. 2009;104:1342–5.

    Article  PubMed  Google Scholar 

  33. Fang X, Wei J, He X, An P, Wang H, Jiang L, et al. Landscape of dietary factors associated with risk of gastric cancer: a systematic review and dose-response meta-analysis of prospective cohort studies. Eur J Cancer. 2015;51:2820–32.

    Article  PubMed  Google Scholar 

  34. Wang XQ, Terry PD, Yan H. Review of salt consumption and stomach cancer risk: epidemiological and biological evidence. World J Gastroenterol. 2009;15:2204–13.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Shikata K, Kiyohara Y, Kubo M, Yonemoto K, Ninomiya T, Shirota T, et al. A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer. 2006;119:196–201.

    Article  CAS  PubMed  Google Scholar 

  36. Peleteiro B, Lopes C, Figueiredo C, Lunet N. Salt intake and gastric cancer risk according to Helicobacter pylori infection, smoking, tumour site and histological type. Br J Cancer. 2011;104:198–207.

    Article  CAS  PubMed  Google Scholar 

  37. Zhong C, Li KN, Bi JW, Wang BC. Sodium intake, salt taste and gastric cancer risk according to Helicobacter pylori infection, smoking, histological type and tumor site in China. Asian Pac J Cancer Prev. 2012;13:2481–4.

    Article  PubMed  Google Scholar 

  38. Bonequi P, Meneses-González F, Correa P, Rabkin CS, Camargo MC. Risk factors for gastric cancer in Latin America: a meta-analysis. Cancer Causes Control. 2013;24:217–31.

    Article  PubMed  Google Scholar 

  39. Lunet N, Valbuena C, Vieira AL, Lopes C, Lopes C, David L, et al. Fruit and vegetable consumption and gastric cancer by location and histological type: case-control and meta-analysis. Eur J Cancer Prev. 2007;16:312–27.

    Article  PubMed  Google Scholar 

  40. Larsson SC, Orsini N, Wolk A. Processed meat consumption and stomach cancer risk: a meta-analysis. J Natl Cancer Inst. 2006;98:1078–87.

    Article  PubMed  Google Scholar 

  41. González CA, Jakszyn P, Pera G, Agudo A, Bingham S, Palli D, et al. Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2006;98:345–54.

    Article  PubMed  Google Scholar 

  42. González CA, Pera G, Agudo A, Palli D, Krogh V, Vineis P, et al. Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int J Cancer. 2003;107:629–34.

    Article  PubMed  Google Scholar 

  43. Steevens J, Schouten LJ, Goldbohm RA, van den Brandt PA. Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. Gut. 2010;59:39–48.

    Article  CAS  PubMed  Google Scholar 

  44. Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control. 2008;19:689–701.

    Article  PubMed  Google Scholar 

  45. Yeh JM, Hur C, Schrag D, Kuntz KM, Ezzati M, Stout N, et al. Contribution of H. pylori and smoking trends to US incidence of intestinal-type noncardia gastric adenocarcinoma: a microsimulation model. PLoS Med. 2013;10:e1001451.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Inoue M, Sasazuki S, Wakai K, Suzuki T, Matsuo K, Shimazu T, et al. Green tea consumption and gastric cancer in Japanese: a pooled analysis of six cohort studies. Gut. 2009;58:1323–32.

    Article  CAS  PubMed  Google Scholar 

  47. Liu H, Hua Y, Zheng X, Shen Z, Luo H, Tao X, et al. Effect of coffee consumption on the risk of gastric cancer: a systematic review and meta-analysis of prospective cohort studies. PLoS One. 2015;10:e0128501.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Tramacere I, Negri E, Pelucchi C, Bagnardi V, Rota M, Scotti L, et al. A meta-analysis on alcohol drinking and gastric cancer risk. Ann Oncol. 2012;23:28–36.

    Article  CAS  PubMed  Google Scholar 

  49. Eom BW, Joo J, Kim S, Shin A, Yang HR, Park J, et al. Prediction model for gastric cancer incidence in Korean population. PLoS One. 2015;10:e0132613.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Buckland G, Travier N, Huerta JM, Bueno-de-Mesquita HB, Siersema PD, Skeie G, et al. Healthy lifestyle index and risk of gastric adenocarcinoma in the EPIC cohort study. Int J Cancer. 2015;137:598–606.

    Article  CAS  PubMed  Google Scholar 

  51. Sugano K. Screening of gastric cancer in Asia. Best Pract Res Clin Gastroenterol. 2015;29:895–905.

    Article  PubMed  Google Scholar 

  52. Choi KS, Jun JK, Suh M, Park B, Noh DK, Song SH, et al. Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the national cancer screening programme in Korea. Br J Cancer. 2015;112:608–12.

    Article  CAS  PubMed  Google Scholar 

  53. Yoshida T, Kato J, Inoue I, Yoshimura N, Deguchi H, Mukoubayashi C, et al. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Int J Cancer. 2014;134:1445–57.

    Article  CAS  PubMed  Google Scholar 

  54. Amiri M, Janssen F, Kunst AE. The decline in stomach cancer mortality: exploration of future trends in seven European countries. Eur J Epidemiol. 2011;26:23–8.

    Article  PubMed  Google Scholar 

  55. de Vries AC, Meijer GA, Looman CW, Casparie MK, Hansen BE, van Grieken NC, et al. Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut. 2007;56:1665–70.

    Article  PubMed  PubMed Central  Google Scholar 

  56. de Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer GA, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008;134:945–52.

    Article  PubMed  Google Scholar 

  57. den Hoed CM, van Eijck BC, Capelle LG, van Dekken H, Biermann K, Siersema PD, et al. The prevalence of premalignant gastric lesions in asymptomatic patients: predicting the future incidence of gastric cancer. Eur J Cancer. 2011;47:1211–8.

    Article  Google Scholar 

  58. Anderson WF, Camargo MC, Fraumeni Jr JF, Correa P, Rosenberg PS, Rabkin CS. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA. 2010;303:1723–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Holster IL, Aarts MJ, Tjwa ET, Lemmens VE, Kuipers EJ. Trend breaks in incidence of non-cardia gastric cancer in the Netherlands. Cancer Epidemiol. 2014;38:9–15.

    Article  PubMed  Google Scholar 

  60. Roosendaal R, Kuipers EJ, Buitenwerf J, van Uffelen C, Meuwissen SG, van Kamp GJ, et al. Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol. 1997;92:1480–2.

    CAS  PubMed  Google Scholar 

  61. den Hoed CM, Vila AJ, Holster IL, Perez-Perez GI, Blaser MJ, de Jongste JC, et al. Helicobacter pylori and the birth cohort effect: evidence for stabilized colonization rates in childhood. Helicobacter. 2011;16:405–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ernst J. Kuipers MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media Singapore

About this chapter

Cite this chapter

Kuipers, E.J. (2016). Gastric Cancer: Synopsis and Epidemiology of Gastric Cancer. In: Kim, N. (eds) Helicobacter pylori. Springer, Singapore. https://doi.org/10.1007/978-981-287-706-2_21

Download citation

  • DOI: https://doi.org/10.1007/978-981-287-706-2_21

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-287-705-5

  • Online ISBN: 978-981-287-706-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics